Skip to main content

Pear Therapeutics, Inc.

PEARDelisted May 2, 2023
Industry
Services-Health Services
SEC CIK
0001835567

Pear Therapeutics, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Apr 12, 2023; 53 institutions reported holding it in 13F filings for Q1 2023, worth $20.7M in total; no superinvestor held it.

Holders of 5% or more of PEAR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pear Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Pear Therapeutics, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Pear Therapeutics, Inc., newest first.

No Schedule 13D or 13G filings on Pear Therapeutics, Inc. are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Pear Therapeutics, Inc. shares.

No Form 144 notices for Pear Therapeutics, Inc. are on file.